Literature DB >> 11499846

Sulfatide storage in visceral organs of arylsulfatase A-deficient mice.

I Schott1, D Hartmann, V Gieselmann, R Lüllmann-Rauch.   

Abstract

The inherited deficiency of arylsulfatase A (ASA) in humans causes lysosomal accumulation of sulfatides in visceral organs and in the nervous system and leads to wide-spread demyelination (metachromatic leukodystrophy, MLD). ASA-deficient mice have previously been generated by means of targeted gene disruption. In the present study, visceral organs of ASA-deficient mice were investigated. A simple technique for the histochemical detection of accumulated sulfatides was elaborated using pre-embedding staining with alcian blue. The gall bladder, intrahepatic bile ducts, exocrine pancreatic ducts, respiratory epithelium and, with low degree, testicular Sertoli cells, showed sulfolipid storage. The storage pattern in the kidney will be described in a separate publication. Hepatocytes, pancreatic islets, adrenal glands, and gastric epithelium were unaffected. Ultrastructurally, the intralysosomal storage material displayed parallel and concentric lamellar patterns. Apart from some differences, the topographic distribution of the sulfatide storage resembled that in human MLD. In addition to being an animal model of the human disease, the ASA-deficient mouse may be useful for investigating the cell biology of sulfolipids in visceral organs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499846     DOI: 10.1007/s004280000360

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  5 in total

Review 1.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

2.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

3.  In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells.

Authors:  Valeska Lizzi Lagranha; Guilherme Baldo; Talita Giacomet de Carvalho; Maira Burin; Maria Luiza Saraiva-Pereira; Ursula Matte; Roberto Giugliani
Journal:  Metab Brain Dis       Date:  2008-09-17       Impact factor: 3.584

4.  Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.

Authors:  S Franken; D Wittke; J E Mansson; R D'Hooge; P P De Deyn; R Lüllmann-Rauch; U Matzner; V Gieselmann
Journal:  Lipids Health Dis       Date:  2006-08-07       Impact factor: 3.876

5.  Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector.

Authors:  Kohei Hironaka; Yoshiyuki Yamazaki; Yukihiko Hirai; Motoko Yamamoto; Noriko Miyake; Koichi Miyake; Takashi Okada; Akio Morita; Takashi Shimada
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.